0001179110-20-010368.txt : 20201009
0001179110-20-010368.hdr.sgml : 20201009
20201009160427
ACCESSION NUMBER: 0001179110-20-010368
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201007
FILED AS OF DATE: 20201009
DATE AS OF CHANGE: 20201009
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldberg Mark Alan
CENTRAL INDEX KEY: 0001532475
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 201233234
MAIL ADDRESS:
STREET 1: 128 SPRING STREET, SUITE 520
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2020-10-07
0
0001597264
Blueprint Medicines Corp
BPMC
0001532475
Goldberg Mark Alan
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2020-10-07
4
M
0
5454
19.53
A
9016
D
Common Stock
2020-10-07
4
S
0
5454
100
D
3562
D
Stock Option (Right to Buy)
19.53
2020-10-07
4
M
0
5454
0
D
2026-06-23
Common Stock
5454
5455
D
Effected pursuant to a trading plan adopted on August 5, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This option was granted on June 23, 2016 and is fully vested as of the date hereof.
/s/ Ariel Hurley, Attorney-in-Fact
2020-10-09